课题基金 / 基金详情

CIHR Training Grant in Neurodegenerative Lipidomics: A Targeted Systems Biology Approach to Integrative Research Training

CIHR Training Grant in Neurodegenerative Lipidomics: A Targeted Systems Biology Approach to Integrative Research Training
CIHR 神经退行性脂质组学培训资助:综合研究培训的靶向系统生物学方法
批准号:
177400
负责人:
Bennett Steffany A
金额:
$130.4万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-11-01 至 2014-11-01

项目摘要

项目成果

Bennett Steffany A的其他基金

相似基金

相关文献

中文摘要
翻译
阿尔茨海默病(AD),其次是帕金森病 (PD)是加拿大最常见和最具破坏性的 神经退行性疾病潜伏的认知和身体 下降使受害者依赖于监护照顾, 每年花费90亿美元。
英文摘要
Alzheimer¿s Disease (AD) followed by Parkinson¿s Disease (PD)are Canada¿s most common and devastating neurodegenerative disorders. Insidious cognitive and physical decline renders victims dependent upon custodial care at an annual cost of $9 billion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipophenomics of Dementia: Sex-specific metabolic determinants of risk and resiliency
  • 批准号:
    462239
  • 项目类别:
    Operating Grants
  • 资助金额:
    $57.68万
  • 财政年份:
    2022
  • 负责人:
    Bennett Steffany A
  • 依托单位:
Lipophenomics of Dementia: Sex-specific metabolic determinants of risk and resiliency
  • 批准号:
    456956
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2021
  • 负责人:
    Bennett Steffany A
  • 依托单位:
Targeting connexin and pannexin communication in demyelinating diseases
  • 批准号:
    328707
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2015
  • 负责人:
    Bennett Steffany A
  • 依托单位:
Aberrant phospholipid and sphingolipid metabolism is a primary and targetable pathology in Alzheimer Disease
  • 批准号:
    291711
  • 项目类别:
    Operating Grants
  • 资助金额:
    $56.75万
  • 财政年份:
    2013
  • 负责人:
    Bennett Steffany A
  • 依托单位:
海外基金